AI-Powered Search available (beta)
Liporotein(a) Lp(a)
ESC content
ESC Premium Access
Thirty-year cardiovascular outcomes in women based on C-reactive protein, LDL cholesterol, and lipoprotein(a)
1 September 2024
14:35
CET
Europe/Paris A global perspective of Lp(a) levels in patients with coronary heart disease - Implications for risk factor control & future trials from the INTERASPIRE Study Access event page https://esc365.escardio.org/event/undefined 2024-09-01T14:35:00 2024-09-01T14:47:00
ESC Premium Access
A global perspective of Lp(a) levels in patients with coronary heart disease - Implications for risk factor control & future trials from the INTERASPIRE Study
2 September 2024
10:00
CET
Europe/Paris Coronary atherosclerotic plaque burden and characterization by spectral computed tomography scan in patients with high lipoprotein a and non-hemodynamically significant stenosis Access event page https://esc365.escardio.org/event/undefined 2024-09-02T10:00:00 2024-09-02T10:50:00
ESC Premium Access
Coronary atherosclerotic plaque burden and characterization by spectral computed tomography scan in patients with high lipoprotein a and non-hemodynamically significant stenosis
ESC Premium Access
Lipoprotein(a) and the risk of major adverse limb events in patients with stable atherosclerotic vascular disease
ESC Premium Access
Lp(a) in clinical practice-risk estimation and how to reduce its associated risk.
ESC Premium Access
Lipoprotein(a) in progressive coronary artery disease: beyond classical cardiovascular risk parameters
Organised by Novartis
Open Access
Lipoprotein(a): a modifiable risk factor of atherosclerotic cardiovascular disease
ESC Premium Access
Lp(a) and cardiovascular risk: integrating perspectives for a holistic approach
ESC Premium Access
